On March 8, 2018, Martin Shkreli was sentenced to seven years’ imprisonment for committing securities fraud and securities fraud conspiracy.  A jury found that Shkreli, a former hedge fund manager and CEO of the biopharmaceutical company Retrophin Inc., made false representations and omissions to defraud investors.  Shkreli was also convicted, alongside former Retrophin outside counsel Evan Greebel, of illegally attempting to control the price and trading volume of Retrophin’s stock.  In addition to his prison term, Shkreli was ordered to pay a $75,000 fine and forfeit $7.3 million. United States v. Shkreli, 15-cr-00637 (E.D.N.Y.)

DOJ Press Release

Related Proceeding Post